tradmap

INNV InnovAge Holding Corp.

$8.91 -2.94%

Data as of close

Healthcare · Services-Health Services

InnovAge Holding Corp. (INNV) is a healthcare company in the Services-Health Services industry, with a market capitalization of $1.2 billion. Shares last traded at $8.91, 36.4% below their 52-week high. Over the past year the stock is up 95.0%. Net profit margin is -0.3%, below the peer median of 0.5%. Revenue grew 15.9% year over year.

Market Cap
$1.2B
Shares Out
136.5M
EPS (TTM)
-$0.02
P/E (TTM)*
—
P/S Ratio
1.23
P/B Ratio
5.16
Dividend / Share
—
Dividend Yield
—
52-Week High
$14.00
52-Week Low
$3.94
Volume (venue)
28,958
Avg Vol (3m, venue)
27,934.063

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-3.78%
1M
-0.39%
3M
-17.73%
6M
+9.33%
YTD
+71.35%
1Y
+94.97%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
39.94
SMA (50)
$9.80
SMA (200)
$9.08
Price vs SMA50
-9.09%
Price vs SMA200
-1.86%
ATR (14)
$0.59

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$990M
Net Income
-$3M
Gross Margin
23.0%
Operating Margin
0.3%
Net Margin
-0.3%
Return on Equity
-1.1%
Return on Assets
-0.5%
Current Ratio
1.05
Debt / Equity
0.21
Revenue Growth (YoY)
+15.9%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q4 2026 (derived) $0.06 2026-09-09
FY 2026 -$0.02 2026-09-09
Q3 2026 -$0.22 2026-05-08
Q2 2026 $0.08 2026-02-03
Q1 2026 $0.06 2025-11-04
Q4 2025 (derived) $0.00 2025-09-09

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-Health Services peers

INNV vs 13 industry peers (Services-Health Services), by market cap. Data as of close

P/S vs peers
1.23 / 1.42 med
-14% discount
Net margin vs peers
-0.3% / 0.5% med
below median
1–13 of 13
LFSTLifestance Health Group, Inc.$5.1B100.163.203.2%-1.08%
PRVAPrivia Health Group, Inc.$2.7B96.601.151.2%-0.98%
WGSGenedx Holdings Corp.$1.9B—4.21-23.4%-7.17%
PNTGPennant Group, Inc.$1.4B43.841.292.9%-2.73%
USPHU S Physical Therapy Inc /Nv$1.3B39.391.564.0%-0.65%
INNVInnovAge Holding Corp.$1.2B—1.23-0.3%-2.94%
OMDAOmada Health, Inc.$1.1B253.973.531.4%-4.77%
ALPSAlps Group Inc$53M———-2.14%
EUDAEUDA Health Holdings Ltd$30M—4.40-40.7%-9.52%
DCGODocGo Inc.$21M—0.07-65.3%-14.63%
PIIIP3 Health Partners Inc.$13M—0.01-10.1%-7.10%
ATPCAgape ATP Corp$1M———-12.67%
PIIIWP3 Health Partners Inc.————-16.00%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.